SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-357430
Filing Date
2021-12-15
Accepted
2021-12-15 08:02:33
Documents
16
Period of Report
2021-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d263426d8k.htm   iXBRL 8-K 66514
2 EX-2.1 d263426dex21.htm EX-2.1 651950
3 EX-2.2 d263426dex22.htm EX-2.2 390574
4 EX-2.3 d263426dex23.htm EX-2.3 82058
5 EX-10.1 d263426dex101.htm EX-10.1 94511
  Complete submission text file 0001193125-21-357430.txt   1707648

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA neog-20211213.xsd EX-101.SCH 2886
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20211213_lab.xml EX-101.LAB 17374
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20211213_pre.xml EX-101.PRE 10949
9 EXTRACTED XBRL INSTANCE DOCUMENT d263426d8k_htm.xml XML 3261
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 211493122
SIC: 2835 In Vitro & In Vivo Diagnostic Substances